Catherine Tang is an Endocrinology/Metabolic physician affiliated with Stony Brook University. OpenAlex indexes 18 publications with 1,376 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
330 Brookline Ave
Gryzmish 6
Boston, MA 022155400
Telephone
617-667-9344Provider last certified this registry record 27 Feb 2020.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Tandem Diabetes Care, Inc.Program year20251 payment
- Abbott LaboratoriesProgram year20251 payment
- Abbott LaboratoriesProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
97.1%Other drugs affecting bone structure and mineralization85.2%Romosozumab-aqqg100%Part B, office-administered≥12 patientsRANK Ligand Inhibitor11.6%Denosumab100%Part B, office-administered≥20 patients+ 1 more class in this area
Metabolism & gastrointestinal
1.7%Insulin Analog0.7%Lantus Solostar59%Humalog Kwikpen U-10018%Novolog Flexpen13%Insulin Lispro Kwikpen U-10010%Part D<11 patientsGLP-1 receptor agonist0.6%Mounjaro41%Ozempic30%Trulicity28%Part D<11 patients+ 4 more classes in this area
Hormonal (systemic)
0.9%l-Thyroxine0.6%Levothyroxine Sodium76%Synthroid24%Part D<11 patientsThyroid Hormone Synthesis Inhibitor0.2%Methimazole100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Ramin Parsey, MD, PhD
Stony Brook University
Basil Rigas, MD
Stony Brook University
Bettina Fries, MD
Stony Brook University
Nancy Epstein, MD
Stony Brook University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”